Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors

MAO-B inhibitors are frequently used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Due to the limited number of compounds available in this field, there is a need to develop new compounds. In the recent works, it was shown that various thiosemicarbazone derivati...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmaniye, Derya, Kurban, Berkant, Sağlık, Begüm Nurpelin, Levent, Serkan, Özkay, Yusuf, Kaplancıklı, Zafer Asım
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587871/
https://www.ncbi.nlm.nih.gov/pubmed/34771054
http://dx.doi.org/10.3390/molecules26216640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587871/
https://www.ncbi.nlm.nih.gov/pubmed/34771054
http://dx.doi.org/10.3390/molecules26216640

Ejemplares similares